Metropolitan Life Insurance Company (MetLife)’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,129
| Closed | -$98.9K | – | 2481 |
|
|
2023
Q2 | $98.9K | Buy |
2,129
+114
| +6% | +$5.3K | ﹤0.01% | 1022 |
|
|
2023
Q1 | $57.7K | Sell |
2,015
-208
| -9% | -$5.96K | ﹤0.01% | 1312 |
|
|
2022
Q4 | $69.4K | Buy |
2,223
+375
| +20% | +$11.7K | ﹤0.01% | 1276 |
|
|
2022
Q3 | $37.5K | Hold |
1,848
| – | – | ﹤0.01% | 1652 |
|
|
2022
Q2 | $28.7K | Buy |
1,848
+711
| +63% | +$11K | ﹤0.01% | 1847 |
|
|
2022
Q1 | $21.8K | Sell |
1,137
-3,377
| -75% | -$64.6K | ﹤0.01% | 2050 |
|
|
2021
Q4 | $114K | Buy |
+4,514
| New | +$114K | ﹤0.01% | 2399 |
|